About us

At HelixHarbor, our mission is to guide biotechnology companies and investment firms through the dynamic realm of biotech investment evaluation.

Drawing on our expertise in analyzing large-scale molecular data, we specialize in evaluating cutting-edge clinical algorithms and models, ensuring robust biomarkers. This commitment empowers clients with the insights needed for informed investment and clinical decisions, underscoring our dedication to advancing the intersection of biotechnology and investment in an ever-evolving landscape.

Rob Seitz

Brian Ring

Managing partner

Partner

Our commercialization success